Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries

Christine Leopold, Aukje Katja Mantel-Teeuwisse, Sabine Vogler, Kees de Joncheere, Richard Ogilvie Laing and Hubert G.M. Leufkens

Health Policy, 2013, vol. 112, issue 3, 209-216

Abstract: Previous studies have suggested that medicines prices in Europe converge over time as a result of policy measures such as external price referencing.

Keywords: Medicines price comparison; Financial recession; Europe; On-patent medicines (search for similar items in EconPapers)
Date: 2013
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (6)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S016885101300225X
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:112:y:2013:i:3:p:209-216

DOI: 10.1016/j.healthpol.2013.08.012

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().